Hercules Capital, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Hercules Capital, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $339.74M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $262.97M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $337.48M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $102.08M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $174.16M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $227.26M | Feb 16, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.58B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $3.83B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $3.42B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $3.03B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $2.60B | Feb 16, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.37B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.84B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.61B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.63B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.29B | Feb 16, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.22B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.99B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.80B | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $1.40B | Feb 12, 2026 |
| FY2025 | Dec 31, 2021 | $1.31B | Feb 12, 2026 |
| FY2025 | Dec 31, 2020 | $1.29B | Feb 12, 2026 |
| FY2025 | Dec 31, 2019 | $1.13B | Feb 12, 2026 |
| FY2025 | Dec 31, 2018 | $955.44M | Feb 12, 2026 |
| FY2025 | Dec 31, 2017 | $840.97M | Feb 12, 2026 |
| FY2025 | Dec 31, 2016 | $787.94M | Feb 12, 2026 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 16, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 16, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.87M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $42.68M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $98.10M | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $14.62M | Feb 13, 2025 |
| FY2023 | Dec 31, 2021 | $133.12M | Feb 15, 2024 |
| FY2022 | Dec 31, 2020 | $198.28M | Feb 16, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.29B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $1.55B | Feb 13, 2025 |
| FY2023 | Dec 31, 2022 | $1.57B | Feb 15, 2024 |
| FY2022 | Dec 31, 2021 | $1.24B | Feb 16, 2023 |